These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10216102)
1. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102 [TBL] [Abstract][Full Text] [Related]
2. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145 [TBL] [Abstract][Full Text] [Related]
3. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Bantel H; Engels IH; Voelter W; Schulze-Osthoff K; Wesselborg S Cancer Res; 1999 May; 59(9):2083-90. PubMed ID: 10232592 [TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221 [TBL] [Abstract][Full Text] [Related]
5. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Chlichlia K; Peter ME; Rocha M; Scaffidi C; Bucur M; Krammer PH; Schirrmacher V; Umansky V Blood; 1998 Jun; 91(11):4311-20. PubMed ID: 9596680 [TBL] [Abstract][Full Text] [Related]
6. Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. Park IC; Park MJ; Hwang CS; Rhee CH; Whang DY; Jang JJ; Choe TB; Hong SI; Lee SH Cancer Lett; 2000 Oct; 158(2):125-32. PubMed ID: 10960761 [TBL] [Abstract][Full Text] [Related]
7. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821 [TBL] [Abstract][Full Text] [Related]
9. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Juo P; Kuo CJ; Yuan J; Blenis J Curr Biol; 1998 Sep; 8(18):1001-8. PubMed ID: 9740801 [TBL] [Abstract][Full Text] [Related]
10. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. Vercammen D; Brouckaert G; Denecker G; Van de Craen M; Declercq W; Fiers W; Vandenabeele P J Exp Med; 1998 Sep; 188(5):919-30. PubMed ID: 9730893 [TBL] [Abstract][Full Text] [Related]
11. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. Lüschen S; Ussat S; Scherer G; Kabelitz D; Adam-Klages S J Biol Chem; 2000 Aug; 275(32):24670-8. PubMed ID: 10827087 [TBL] [Abstract][Full Text] [Related]
12. The involvement of caspases in the CD95(Fas/Apo-1)- but not swelling-induced cellular taurine release from Jurkat T-lymphocytes. Lang F; Madlung J; Siemen D; Ellory C; Lepple-Wienhues A; Gulbins E Pflugers Arch; 2000 May; 440(1):93-9. PubMed ID: 10864002 [TBL] [Abstract][Full Text] [Related]
13. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling. Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562 [TBL] [Abstract][Full Text] [Related]
14. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2. Dirsch VM; Stuppner H; Vollmar AM Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221 [TBL] [Abstract][Full Text] [Related]
15. Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells. Fulda S; Scaffidi C; Pietsch T; Krammer PH; Peter ME; Debatin KM Cell Death Differ; 1998 Oct; 5(10):884-93. PubMed ID: 10203687 [TBL] [Abstract][Full Text] [Related]
16. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. Sun XM; MacFarlane M; Zhuang J; Wolf BB; Green DR; Cohen GM J Biol Chem; 1999 Feb; 274(8):5053-60. PubMed ID: 9988752 [TBL] [Abstract][Full Text] [Related]
17. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. MacFarlane M; Cohen GM; Dickens M Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718 [TBL] [Abstract][Full Text] [Related]
18. CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-1/WAF-1, which promotes apoptosis. Hingorani R; Bi B; Dao T; Bae Y; Matsuzawa A; Crispe IN J Immunol; 2000 Apr; 164(8):4032-6. PubMed ID: 10754295 [TBL] [Abstract][Full Text] [Related]
19. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation. Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]